Theme: New insights in prevention and management of diabetes through intervening technologies
Diabetic Medications-2015
Being recognized as a world-renowned organization, OMICS Group International takes pride to introduce the commencement of “International Conference on Targeting Diabetes and Novel Therapeutics” from September 14 - 16, 2015 at Las Vegas, Nevada, USA. Special interest and theme of this conference is: “New insights in prevention and management of diabetes through intervening technologies”. The conference aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. OMICS Group’s Diabetic Medications conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.
OMICS Publishing Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Publishing Group hosts over 400 leading-edge peer reviewed Open Access journals and has organized over 300 scientific conferences all over the world.
OMICS Group welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine to attend this Diabetes Conferences, where all the aspects of diabetes will be discussed under single roof. Diabetic Medications-2015 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.
Diabetic Medications-2015 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetic Medications-2015 is where the future of management and novel therapeutics for the disease intersects.
Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. As the number of patients grows across the globe, there has never been a stronger and more urgent need for novel therapeutic measures in clinical and preclinical evaluation, that arrest the growth of the disease. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly. The global market value for diabetes therapies and diagnostics has reached to $48.5 billion. The largest segment of the market, insulin products, is worth $20.8 billion in the recent times, including administration and diagnostic devices. Monitoring devices and other related equipment, the second-largest market is established with an investment of $13.5 billion in which was proposed for $11.3. The fastest-growing segment of oral diabetic hypoglycemia drugs manufacturing funding is $14.13 in present scenario of diabetes market. For more...
Why Las Vegas (Nevada)?
Diabetes is the 10th leading cause of death in Nevada (vs. 7th in the United States). Nevada is currently ranked 16th out of all states in diabetes prevalence. In 2010, 7.9% of Nevada’s population reported having been diagnosed with diabetes (over 160,000 people). Although Nevada has been improving its relative position in the state-by-state rankings, diabetes prevalence in Nevada has been increasing over the past 20 years. Estimates are that the total cost of diabetes in Nevada will exceeds $17.3 billion by 2015, including lost work productivity and direct medical bills. About equal percentages of men and women in Nevada have clinically diagnosed diabetes, but men have a higher mortality rate from diabetes than do women. Rates are highest among older Nevadans (aged 55 and older). In terms of race/ethnicity, blacks have the highest diabetes rate and diabetes mortality rate in Nevada while whites have the lowest diagnosis rate and whites and Hispanics have the lowest diabetes mortality rates.
Type-1 Diabetes is normally seen in Children and Young adults. It is caused due to low secretion of insulin. This means the need of regular insulin treatment to keep your glucose levels normal. There's no cure for diabetes, so treatment aims to keep blood glucose levels as normal and to control the symptoms to prevent health problems developing later in life.
The goal is to keep the daytime blood sugar levels before meals between 70 and 130 mg/dL (3.9 to 7.2 mmol/L) and after meal numbers no higher than 180 mg/dL (10 mmol/L) two hours after eating. The global treatment market for Type 1 Diabetes (T1D) will expand from $6.6 billion in 2013 to an estimated $13.6 billion by 2023, representing a Compound Annual Growth Rate (CAGR) of 7.6%, according to research. Primary care of Diabetes, Restoring and maintaining normal pancreas function through Beta Cell Regeneration, Islet transplantation, Genetic Engineering and Recombinant DNA technology approaches are some of the Novel therapeutic targets for diabetes.
Type 2 Diabetes- Therapies and treatments
Type 2 Diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes Federation, more than 317 million people have been diagnosed with diabetes, and an additional 187 million are living undiagnosed. The global revenue earned from drugs sales to treat type 2 diabetes was approximately $36.89 billion in 2012 that is rapidly increasing in incidence and prevalence across the globe predicated to elevate this figure to approximately $68.42 billion by 2017. Patients with this disease cannot use glucose properly for their body needs. Self-monitoring of Blood glucose levels, Lifestyle modifications and Health eating habits are crucial in combating the critical manifestations of this disease which may require proper diabetic nursing. This may also include considerable amount of time educating patients and families on proper dietary, exercise and lifestyle habits to keep symptoms under control.
Alternative Treatment for Diabetes
Diabetes mellitus is a dreadful disease and is found in all parts of the world, becoming a serious threat of mankind health. There are lots of chemical agents available to take control on the disease, but total recovery from diabetes is the question to the treatment. Alternative to these synthetic agents, plants provided a potential source of natural cure of hypoglycemic drugs and are widely used in several traditional systems of medicine to prevent Prediabetes. Other alternative therapies such as Diabetic supplements, acupuncture, hydrotherapy, and yoga therapies are reported to have less likely side effects of conventional approaches for diabetes.
With the growing awareness and information regarding preventive measures for combating fatal disease like diabetes, consumers are opting for proper food along with medicines. One can improve the health in a big way by making small changes to the diet, while still enjoying the favorite foods and taking pleasure from the meals. A diabetes diet is simply a healthy eating plan that is high in nutrients, low in fat, and moderate in calories. Manufacturers are now keen on introducing new low calorie food products with sugar substitutes and less oil, in view of the increasing consumer interest toward healthy eating and help prevent diabetes and its concomitant risk factors
The global diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of lifestyles and obesity in global population. The diabetes treatment products include injectable diabetes drugs, oral drugs, insulin therapies, insulin pumps, insulin injection devices and blood glucose monitoring systems . According to the new report the world market for diabetes medications will reach $55.3bn in 2017. The anti-diabetic medicines industry generated $35.6bn in 2012, and its revenues will show strong growth to 2023. Monitoring glucose levels is critical for the management of diabetes and new and improved portable, less costly, easy-to-use, accurate and virtually painless blood glucose monitoring systems are now available to take control of the disease.
Diabetes Research in Clinical Practice
Novel therapeutic targets available for diabetes includes Incretin based therapies, oral therapeutic agents like secretagogues, beta cell regeneration & proliferation and stem cell therapies. Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Apart from the above, various computational approaches in Diabetes management have been introduced recently which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These processes are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction.
Advanced Medications for Diabetes Complications
With rising numbers of diagnosed diabetics, pharmaceutical manufacturers have capitalized on the burgeoning market for diabetes therapies. Manufacturers' efforts to develop non-invasive methods of insulin delivery are set to revolutionize the insulin therapy market, while demand for oral medications is on the upswing due to a growing type II diabetic population and introduction of technologically advanced therapies. With human embryonic stem cells as a starting point, the scientists are for the first time able to produce, in the kind of massive quantities needed for cell transplantation and pharmaceutical purposes, human insulin-producing beta cells equivalent in most every way to normally functioning beta cells. This will certainly help people recover the prognosis of the fatal disease.
Computational Biology of Diabetes
Computational meta-analysis can link environmental chemicals to genes and proteins involved in human diseases, thereby elucidating possible etiologies. The recent rapid development of a variety of analytical platforms based on mass spectrometry and nuclear magnetic resonance have enabled identification of complex metabolic syndrome phenotypes. Continued development of bioinformatics and analytical strategies has facilitated the discovery of causal links in understanding the pathophysiology of diabetes and its complications.
Recent Research and Advanced Technologies for Diabetes care
Current Research in diabetes is focusing on developing Implantable insulin pumps which introduced Insulin pump therapy, disruption of fat metabolism, invasive and non-invasive glucose sensors, Artificial pancreas, New insulin delivery systems like inhaled, transdermal and implantable devices, Insulin Pens, Bariatric surgery and Conventional therapeutic approaches. Traditional approaches like Acupuncture and herbal medications are playing vital role in treatment of Diabetes.
Risk factors and related diseases of Diabetes
Diabetes is always accompanied by a number of serious health issues. Consistent increase in blood glucose levels can lead to serious diseases affecting the vital organs of body like heart and blood vessels, eyes, kidneys, nerves and teeth. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease like diabetic cardiomyopathy being one of the major risk factor, blindness, kidney failure, and lower limb amputation. Diabetic Retinopathy causes progressive damage to the retina in the patients with diabetes adding as the most vulnerable risk for the patient. Maintaining blood glucose levels, blood pressure, diabetic gastro paresis which has been reported to have the main cause as Diabetes Mellitus and cholesterol at or close to normal can help delay or prevent diabetes complications.
“International Conference on Targeting Diabetes and Novel Therapeutics” is going to be held during September 14 - 16, 2015 at Las Vegas, Nevada, USA. The special interest and theme of this conference is: “New insights in prevention and management of diabetes through intervening technologies”. Diabetic Medications conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.
For more details please visit- http://diabeticmedications.conferenceseries.com/
Importance & Scope
Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. According to WHO Diabetes was estimated to affect 371 million people till the end of 2011in US. Whereas, new figures indicate that the number of people living with diabetes is expected to rise from 371 million in 2012 to 552 million by 2030. This indicates an urgent alarm for its management.
As the number of patients grows across the globe, there has never been a stronger and more urgent need for therapeutic measures that arrest the growth of the disease and alleviate its secondary manifestations. In Type 1 diabetes total β-cell loss occurs. In Type 2 diabetes, partial β-cell loss occurs before diagnosis, and the progressive β-cell loss during the life of the patient increases the severity of the disease. This addresses novel therapies for these deficiencies in clinical and preclinical evaluation.
Many International Conferences and Diabetic therapies meetings/ symposium and workshops have been organized on different topics related to the risk factors related to diabetes across the globe such as glucose tolerability conference, diabetes stem cell cure conference, anti-diabetic agents meetings, obesity conferences, weight loss conferences, Islet transplantation international conference, glucose variability conferences etc. Besides that many international events such as diabetes alternative medicines events, insulin pump therapy events, pancreatic dysfunction events, recombinant approaches for diabetes events etc. Targeted Therapy Events have been also taking place in order to find a weapon against fatal diseases like diabetic foot, insulin resistance, glucose tolerability, obesity and to discuss the role of diabetes in cardiovascular diseases, kidney diseases, risk of cancer and intolerability to cure the wound which will gives a better insight about the associated causes and disease portfolio.
OMICS Group welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine to attend this Diabetes Conference, where all the aspects of diabetes will be discussed under single roof. Diabetic Medications-2015 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.
Diabetic Medications-2015 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetic Medications-2015 is where the future of management and novel therapeutics for the disease intersects.
Why Las Vegas (Nevada)?
Diabetes is the 10th leading cause of death in Nevada (vs. 7th in the United States). Nevada is currently ranked 16th out of all states in diabetes prevalence. In 2010, 7.9% of Nevada’s population reported having been diagnosed with diabetes (over 160,000 people). Although Nevada has been improving its relative position in the state-by-state rankings, diabetes prevalence in Nevada has been increasing over the past 20 years. Estimates are that the total cost of diabetes in Nevada will exceeds $17.3billion by 2015, including lost work productivity and direct medical bills.
About equal percentages of men and women in Nevada have clinically diagnosed diabetes, but men have a higher mortality rate from diabetes than do women. Rates are highest among older Nevadans (aged 55 and older). In terms of race/ethnicity, blacks have the highest diabetes rate and diabetes mortality rate in Nevada while whites have the lowest diagnosis rate and whites and Hispanics have the lowest diabetes mortality rates.
Why to attend???
Medical doctors, patients and health care providers consider the prevention of Diabetes diseases as an essential tool to improve the general health status of the population. The proportions of people suffering from the disease are expected to increase in future according a recent statistical survey. According to recent statistics, diabetes diseases worldwide will double between 2012 and 2030. Realizing this imperative, OMICS Group is set to organize International Conference on Targeting Diabetes and Novel Therapeutics this year with a view to enhance research and promote awareness aiming in developing solutions for the challenges encountered. Diabetic Medications-2015 will comprise of many leading keynote speakers and session speakers who will be delivering their speech on the current research topics of Type 1 and Type 2 diabetes therapeutics, complications related to diabetes and other risk factors associated with the disease. The young researchers and the student participants will gain the opportunity to grab the Best Poster Award by presenting their work as a poster presentation and Young Researcher Forum.
Associations Associated with Diabetes Research
To encourage, educate, update and train registered medical practitioners, dieticians, qualified nurses and other appropriately qualified paramedical personnel in the field of Diabetes various well-known societies/associations are working across the globe to efficiently prevent and combat the fatal disease.
Major Diabetes Associations in Las Vegas
- Nevada Diabetes association
- Las Vegas Diabetes Lion Club
- American diabetes association, Salt Lake City, Utah
- Diabetes association North Las Vegas
- Juvenile Diabetes Las Vegas
- Nevada Retina Center
- The Dellon Institute
- Joslin Diabetes Center Partner with Fremont Medical Center in Las Vegas
- Diabetes Education in Tribal Schools (DETS)
- National Institute of Diabetes and Digestive and Kidney Diseases, Las Vegas
Major Diabetes Associations in USA
- American Diabetes Association
- American Association of Clinical Endocrinologists
- Centers for Disease Control: Division of Diabetes Translation
- Diabetes Advocacy Alliance
- Diabetes Hands Foundation
- Juvenile Diabetes Foundation International
- National Kidney Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases
Major Diabetes Associations around the Globe
- Diabetes Indian Association
- Canadian Diabetes Association
- International Diabetes Federation
- Diabetes Australia
- Austrian Diabetes Association.
- Diabetes UK
- Diabetes South Africa.
- Spanish Diabetes Society (Spain).
- Swedish Diabetes Association.
- Korean Diabetes Association
Statistical Analysis of Associations
Universities Associated with Diabetes Research
There are around 5000 medical universities in the world out of which approximately 3000 universities focusing on Endocrinology and Diabetes researches.
Top Universities in Las Vegas
- University of Nevada School of Medicine
- Touro University Nevada
- Loma Linda University
- University of Nevada – Reno
- PIMA Medical Institute
- Anthem Education, Nevada
- Carrington College, Las Vegas
- University Medical Center
- College of southern Nevada
- Western Nevada College
Top Universities in Nevada
- University of Nevada – Reno
- Walden University
- University of Phoenix
- Saint Joseph's University
- Capella University
Top Medical Universities for Diabetes in USA
- Albany Medical College
- Baylor College of Medicine
- Creighton University School of Medicine
- Dartmouth Medical School
- Florida International University College of Medicine
- Georgetown University School of Medicine
- Howard University College of Medicine
- Harvard Medical School
- Johns Hopkins University School of Medicine
- Pennsylvania State University College of Medicine
Hospitals Associated with Diabetes Research
Over 29.1 million people (9.3 percent) of the U.S. population currently has diabetes, reports the Centers for Disease Control, and it is an epidemic that seems to be growing. Not only is diabetes detrimental to one’s health, but it is also a costly disease to treat. The total estimated cost of diagnosed diabetes in 2012 was $245 billion, according to the ADA, including $176 billion in direct medical costs and $69 billion in reduced productivity.
- Mayo Clinic, Rochester, Minn
- Ohio's Cleveland Clinic.

- Massachusetts General Hospital, Boston
- Johns Hopkins Hospital, Baltimore
- University of California, San Francisco Medical Center
- Ronald Reagan UCLA Medical Center, Los Angeles
- Cleveland Clinic
- New York-Presbyterian University Hospital of Columbia and Cornell
- Yale-New Haven Hospital, New Haven
- Barnes-Jewish Hospital/Washington University, St. Louis
- Brigham and Women's Hospital, Boston
Major Diabetes Hospitals in Las Vegas (Nevada)
- Horizon Specialty Hospital
- Valley Hospital Medical Center
- North Vista Hospital
- University Medical Center
- Sunrise Hospital & Medical Ctr
- Healthsouth Rehab Hospital
- Desert Springs Hospital Med Ctr
- Kindred Hospital
- Progressive Hospital
- Harmon Medical & Rehab Hospital
Target Audience
Diabetic Medications conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research. Following are the areas for targeting the audience percentage wise:
Scientists 60%
Academia 30%
Others 10%
Companies Associated with Diabetic products and their funding
The top ten pharmaceutical companies based on global anti-diabetic revenue in 2014 and a projection for 2020, in million U.S. dollars are as follows:
Glance at Market of Diabetes
Global Market for Diabetes Therapies & Diagnostics is to be worth $51.2 billion in 2015. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly.
According to a new technical market research report, 'Diabetes Therapies and Diagnostics' from BCC Research, the global market value for diabetes therapies and diagnostics is an estimated $38 billion in 2010, but is expected to increase to $51.2 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 6.1 per cent.The largest segment of the market, insulin products (including administration devices), is estimated to be worth $16.4 billion in 2010, and is expected to increase at a CAGR of 6.1 per cent to reach $22 billion in 2015.
Monitoring devices and accessories, the second-largest segment, is expected to reach $14.1 billion in 2015, after increasing from the 2010 estimate of $11.3 billion at a CAGR of 4.5 per cent. The fastest-growing segment, oral hypoglycemic drugs, is projected to increase at a CAGR of 8 per cent, increasing from an estimated $10.3 billion in 2010 to $15.1 billion in 2015.
Statistics which shows growth in Diabetic Products
National Institute of Health (NIH) funding for Diabetes
- Joslin Diabetes Center (JDC), Boston: $12,507,035
- Thermalin Diabetes(TD) , Cleveland: $2930606
NIH funding for diabetes (year wise)
Future Diabetes projection
A recent study projects that 53.1 million Americans will have diabetes in the year 2025, representing a 63% increase from the number with diabetes today.The cost of diabetes is projected to rise to $514 billion in 2025, representing an increase of 72% from today’s figures and comparable to the entire Medicare budget for 2010.
Data reported by researchers states that assuming low diabetes incidence, and relatively high diabetes mortality, overall prevalence of diabetes in the US population could rise from 14% in 2010 to 21% in 2050. Also, assuming recent increases in diabetes incidence continue, and diabetes mortality is low, then the overall prevalence of diabetes in the US population could rise from 14% in 2010 to 33% in 2050.
Conference Highlights
- Diabetes Medications
- Type 2 Diabetes- Therapies and treatments
- Alternative Treatment for Diabetes
- Diabetic Diet and Prevention
- Diabetic Cure and Diagnosis
- Diabetes Research In Clinical Practice
- Islet Transplantation and Beta cell targeting
- Advanced Medications for Diabetes Complications
- Computational Biology of Diabetes
- Recent Research and Advanced Technologies for Diabetes care
- Risk factors and related diseases of Diabetes
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
| Conference Date | September 14-16, 2015 | ||
| Sponsors & Exhibitors |
|
||
| Speaker Opportunity Closed | Day 1 | Day 2 | Day 3 |
| Poster Opportunity Closed | Click Here to View | ||